HCM Q3 2019 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$49M-16.1% YoY

Gross Profit

-$20M-41.2% margin

Operating Income

-$36M-72.8% margin

Net Income

-$31M-63.0% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

-1.4%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$454M

Total Liabilities

$116M

Stockholders' Equity

$314M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$59M	-16.1%
Gross Profit	-$20M	-$3M	-554.5%
Operating Income	-$36M	-$15M	-143.0%
Net Income	-$31M	-$26M	-21.6%